Bridgeway Capital Management’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-15,600
| Closed | -$6.79K | – | 1453 |
|
|
2022
Q4 | $6.79K | Sell |
15,600
-89,800
| -85% | -$39.1K | ﹤0.01% | 1360 |
|
|
2022
Q3 | $30K | Sell |
105,400
-50,000
| -32% | -$14.2K | ﹤0.01% | 1377 |
|
|
2022
Q2 | $56K | Sell |
155,400
-89,500
| -37% | -$32.3K | ﹤0.01% | 1277 |
|
|
2022
Q1 | $164K | Sell |
244,900
-100,000
| -29% | -$67K | ﹤0.01% | 1201 |
|
|
2021
Q4 | $445K | Sell |
344,900
-69,000
| -17% | -$89K | 0.01% | 1013 |
|
|
2021
Q3 | $898K | Buy |
413,900
+115,600
| +39% | +$251K | 0.02% | 858 |
|
|
2021
Q2 | $814K | Sell |
298,300
-20,000
| -6% | -$54.6K | 0.01% | 923 |
|
|
2021
Q1 | $831K | Buy |
+318,300
| New | +$831K | 0.02% | 929 |
|